Connect with us
Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.


Captivate Bio Launches with First Round of High-Quality Cell Culture Tools


Captivate Bio, a newly formed scientific solutions provider headquartered in Watertown, Massachusetts, emerged from stealth mode today to announce it has successfully launched its portfolio of cell culture tools to assist in the fight against COVID-19 and other emerging diseases as well as help address the gaps exposed by supply chain issues and delays in cell culture media manufacturing here in the United States.

Captivate Bio initiated operations in June 2020 and has achieved several critical milestones including the first product shipment to customers in just 2 short months while inking key scientific collaborations which will help fuel the Companys aggressive growth strategy. Founded by and women-led, the management team has extensive experience in media manufacturing, supply chain and commercialization; the company is already transacting and rapidly generating revenue.

Our experience in commercialization and media manufacturing coupled with operational excellence has enabled us to reach these milestones fairly quickly; we are focused on the customer first and in helping researchers get access to tools they need at an affordable price, says Chief Executive, Tanya Potcova. The Captivate Bio teams experience in sourcing raw materials, commercialization, and supply chain know-how has allowed them to successfully launch a portfolio of research products efficiently.

The company holds memberships with Mass Bio, BioCT, and plans for operational expansions are currently underway.

Our team shares a passion for science and the customer. Weve set out on this journey to help researchers solve procurement challenges exposed during this global pandemic, says Lori Oakes, Managing Partner of Captivate Bio. We couldnt be prouder of our small, passionate team that worked tirelessly to get our first products off the shelf. This was truly a team effort.


Captivate Bio is a privately held scientific solutions provider specializing in the commercialization and distribution of high-quality reagents and custom cell culture media services for the research, therapeutic, and healthcare communities. Captivate Bios current focus is in supplying high volume media and supplements to assist in the fight against COVID-19 and future diseases. Current product offering includes viral transport media and collection kits plus classical cell culture media, fetal bovine serum (FBS), human platelet lysate (HPL), and a portfolio of small molecules for stem cell research. Visit or follow-on LinkedIn, Facebook, Instagram, and Twitter.

Captivate Bio

Lori Oakes

(617) 607-4017

Editorial & Advertiser disclosure

Call for Entries

Global Banking and Finance Review Awards Nominations 2022
2022 Awards now open. Click Here to Nominate

Newsletters with Secrets & Analysis. Subscribe Now


Global Banking & Finance Review® is a leading financial portal and Print Magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management. Copyright © 2010-2021 GBAF Publications Ltd - All Rights Reserved.